ArticleJournal of hepatocellular carcinoma2024

Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Jiayun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.